Psychiatric News (9/18) reports, “Adding menopausal hormone therapy (MHT) to antipsychotic medication can lower the risk of relapse or any psychiatric hospitalization in women between 40 and 62 years of age who have schizophrenia, according to” researchers who “analyzed data from 3,488 women.” Researchers wrote in AJP in Advance, “To maximize benefits and minimize risks of MHT, treatment should be individualized using the best available evidence, with periodic reevaluation of continuation.”
Related Links:
— “Hormone Therapy May Reduce Relapse Risk for Menopausal Age Women With Schizophrenia, Psychiatric News, September 18, 2024